Table 7 Cardiac tumors
Sequence | imaging plane | Indication |
|---|---|---|
Standard imaging | ||
Cine bSSFP | Axial and oblique planes across the tumor | Tumor size and location Assessment for potential interference with blood flow or valve function |
Short-axis stack LVOT and RVOT long-axis | Assessment for potential interference with blood flow, valve function, or ventricular function | |
T1-weighted spin echo with and without fat suppression | Across the tumor and uninvolved myocardium | Tumor characterization |
T2-weighted spin echo with fat suppression | Same plane and coverage as T1-weighted sequence | Tumor characterization |
First-pass perfusion | Short-axis 4-chamber | Myocardial and tumor perfusion |
Late gadolinium enhancement | Across the tumor and uninvolved myocardium | Fibrosis |
Additional late gadolinium enhancement imaging 20–30 min post-contrast | As indicated across the tumor and uninvolved myocardium | Strong hyperenhancement may be present in certain cases of large fibromas |
Post-contrast late gadolinium enhancement with long inversion time (600 ms) | As indicated across the tumor and uninvolved myocardium | Suspicion of thrombus |
Additional case-specific or comprehensive imaging | ||
Coronary artery imaging | Coronary artery relationship to tumor | |
Velocity encoded phase contrast flow | Tumor-related obstruction to blood flow and valvular regurgitation | |
Magnetic resonance contrast angiography | Extracardiac vascular anatomy | |